Serious adverse events: hospitalisation · Dialysis vascular access outcomes in AVF patients with ESKD
Omega‐3 fatty acids showed no clear difference in serious adverse events: hospitalisation compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events: cardiovascular events · Dialysis vascular access outcomes in AVF patients with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events: major bleeding · Dialysis vascular access outcomes in AVF patients with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Loss of patency by 12 months · dialysis vascular access outcomes in AVG patients with ESKD
It is very uncertain whether omega‐3 fatty acids changes loss of patency by 6 months compared with placebo (very low certainty).
2 findings from 1 review
Serious adverse events: death · dialysis vascular access outcomes in AVG patients with ESKD
Omega‐3 fatty acids showed no clear difference in serious adverse events: death compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events: hospitalisation · dialysis vascular access outcomes in AVG patients with ESKD
It is very uncertain whether omega‐3 fatty acids changes serious adverse events: hospitalisation compared with placebo (very low certainty).
1 finding from 1 review
HbA1c (%) · people with diabetes and CKD
1 finding from 1 review
FBG (mmol/L) · people with diabetes and CKD
1 finding from 1 review
Death (all causes) · people with diabetes and CKD
1 finding from 1 review
All cardiovascular death · people with diabetes and CKD
1 finding from 1 review
Weight (kg) · people with diabetes and CKD
1 finding from 1 review
eGFR · people with diabetes and CKD
1 finding from 1 review
Hypoglycaemia · people with diabetes and CKD
1 finding from 1 review
Discontinuation of medication due to adverse events · people with diabetes and CKD
1 finding from 1 review
HbA1c (%) · people with diabetes and CKD
1 finding from 1 review
FBG (mmol/L) · people with diabetes and CKD
1 finding from 1 review
Death (all causes) · people with diabetes and CKD
1 finding from 1 review
FBG (mmol/L) · people with diabetes and CKD
1 finding from 1 review
All cardiovascular death · people with diabetes and CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Weight (kg) · people with diabetes and CKD
1 finding from 1 review